Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-10 |
mRNA | ANXA5 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
mRNA | RAB13 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-07 |
mRNA | MCL1 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-10 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
mRNA | HDLBP | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-08 |
mRNA | RARS | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-08 |
mRNA | RAB1A | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-08 |
mRNA | DOLK | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |